pharma
Patient Experience: Living with multiple rare diseases
February 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma, rare disease
Carole Scrafton discusses her experience living with Ehlers-Danlos syndrome alongside other rare conditions that have manifested throughout her life, and …
Eisai releases new Phase 2 data for levatinib+everolimus combo in advanced kidney cancer
February 17, 2020Research and Development, Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, pharma, renal cell carcinoma
New Phase 2 data has been revealed for Eisai’s Lenvima (levatinib), delivered alongside Novartis’ everolimus, for the treatment of unresectable …
Strong Phase 3 data for Takeda’s subcutaneous Entyvio in moderate to severe Crohn’s disease
February 17, 2020Research and Development, Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma
Takeda has shared positive new Phase 3 data on a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab) as a …
Mumps cases in England rocket four-fold to highest point in a decade
February 14, 2020Medical Communications, Research and Development MMR vaccine, Vaccine, anti-vaccine, pharma
The incidence of mumps in the England has reached its highest level in 10 years, prompting warnings from health officials …
Global drug market’s production line threatened by coronavirus
February 14, 2020Medical Communications Chinese Coronavirus, Drug markets, Wuhan Coronavirus, china epidemic, coronavirus, drugs, epidemic, pharma
The global drug market is facing issues over production due to the coronavirus ravaging the supply line from China. In …
Eisai withdraws weight loss drug Belviq after FDA highlights cancer risk
February 14, 2020Medical Communications, Research and Development, Sales and Marketing Belviq, Eisai, FDA, pharma
The FDA has requested that Eisai withdraw its weight loss drug Belviq (lorcaserin) and Belviq XR from the US market …
Sanofi axes four major players from its executive committee
February 13, 2020Manufacturing and Production, Medical Communications Sanofi, appointments, pharma
Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief Executive Officer Paul Hudson, who …
Lilly and Incyte’s atopic dermatitis drug shows promise at Phase 3
February 13, 2020Sales and Marketing Eli Lilly, Incyte, baricitinib, pharma
Eli Lilly and Incyte have pulled back the curtain on Phase 3 data on their oral selective JAK inhibitor baricitinib …
ICR identifies key “microRNA” gene driving chemotherapy resistance in cancer
February 12, 2020Research and Development Cancer, ICR, pharma
Researchers at the Institute of Cancer Research have discovered that a small RNA molecule known as microRNA gene MIR1249 contributes …
Working Life Interview: Dr Andrea Pfeifer, Co-Founder and CEO, AC Immune
February 11, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AC Immune, Interview, Working Life, feature, pharma
What originally set you off on your career path? Was the plan always to go into the pharma and biotech …
Eli Lilly’s solanezumab fails at Phase 2/3 in early-onset Alzheimer’s disease
February 11, 2020Manufacturing and Production Alzheimer's Eli Lilly, pharma, trial failure
In another blow to Alzheimer’s research, it has emerged that a study investigating Eli Lilly’s solanezumab in the treatment of …
Sanofi and Regeneron’s Libtayo approved on NHS Scotland for cutaneous squamous cell carcinoma
February 11, 2020Manufacturing and Production, Sales and Marketing Libtayo, NHS, Regeneron, Sanofi, Scotland, nhs scotland, pharma
Scottish patients will now be able to access Sanofi and Regeneron’s Libtayo (cemiplimab) via the NHS after it became known …
85% of patients see benefit in clinical trials, but 43% were never given the option to participate, report finds
February 7, 2020Medical Communications, Research and Development clinical trials, pharma
Patients regularly find value in participating in clinical trials, but many are not given the option by medical professionals and …
GSK to axe 720 positions at Belgian vaccine facility
February 7, 2020Manufacturing and Production, Medical Communications GSK, job cuts, pharma
GlaxoSmithKline has announced a cull of staff at its vaccine production site in Belgium, with 720 employees facing the axe. …
AbbVie’s Rinvoq hits target in psoriatic arthritis sub-population at Phase 3
February 6, 2020Research and Development AbbVie, Rinvoq, pharma, psoriatic arthritis
AbbVie has unveiled new Phase 3 data on its selective and reversible JAK inhibitor Rinvoq (upadacitinib) in the treatment of …
Latest content
Five Facts about cardiovascular disease
